Rhodiola RoseavsSAMe

Rhodiola modulates the hypothalamic-pituitary-adrenal (HPA) axis and reduces cortisol release under stress, possibly through modulation of glucocorticoid receptor sensitivity. Salidroside and rosavins inhibit catechol-O-methyltransferase (COMT) and monoamine oxidase A and B (MAO-A, MAO-B), slowing the breakdown of dopamine, serotonin, and norepinephrine in the brain — increasing catecholamine availability in the prefrontal cortex and limbic system during stress. Rhodiola activates AMP-activated protein kinase (AMPK), a cellular energy sensor that enhances glucose uptake and mitochondrial biogenesis. It has antioxidant effects via activation of Nrf2 and HO-1, protecting neurons from stress-induced oxidative damage. Salidroside may also modulate opioid peptide (beta-endorphin) release and enhance nitric oxide production.

SAMe serves as the principal methyl donor in over 100 transmethylation reactions catalyzed by SAM-dependent methyltransferases. In the brain, it donates methyl groups to phosphatidylethanolamine N-methyltransferase (PEMT), converting PE to phosphatidylcholine and maintaining neuronal membrane fluidity critical for receptor function. It methylates DNA via DNMT enzymes, modulating gene expression epigenetically. SAMe is essential for catechol-O-methyltransferase (COMT) activity, which metabolizes dopamine and norepinephrine, and for phenylethanolamine N-methyltransferase (PNMT), which converts norepinephrine to epinephrine. It feeds the transsulfuration pathway, producing cysteine via cystathionine beta-synthase (CBS) and cystathionine gamma-lyase, ultimately supporting glutathione synthesis for antioxidant defense. SAMe also donates methyl groups for myelin basic protein methylation, essential for myelin sheath integrity and nerve conduction velocity.